Irish biotech company Metabolomic Diagnostics has secured an additional €2 million in venture funding to help complete PrePsia, its new screening test for first-time pregnant mothers.
This latest funding round is supported by existing investors, SOSventures, Enterprise Equity and Enterprise Ireland as well as a number of other private investors.
The PrePsia blood test is designed to detect the risk of pre-eclampsia early in the pregnancy and ultimately save lives through personalised medical interventions.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team